Authors:
Clavio, M
Gatto, S
Beltrami, G
Cerri, R
Carrara, P
Pierri, I
Canepa, L
Miglino, M
Balleari, E
Masoudi, B
Damasio, E
Ghio, R
Sessarego, M
Gobbi, M
Citation: M. Clavio et al., First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia, LEUK LYMPH, 40(3-4), 2001, pp. 305-313
Authors:
Russo, D
Pricolo, G
Michieli, M
Michelutti, A
Raspadori, D
Bertone, A
Marin, L
Pierri, I
Bucalossi, A
Zuffa, E
De Vivo, A
Mazza, P
Gobbi, M
Lauria, F
Zaccaria, A
Baccarani, M
Citation: D. Russo et al., Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia, LEUK LYMPH, 40(3-4), 2001, pp. 335-343
Authors:
Visani, G
Bernasconi, P
Boni, M
Castoldi, GL
Ciolli, S
Clavio, M
Cox, MC
Cuneo, A
Del Poeta, G
Dini, D
Falzetti, D
Fanin, R
Gobbi, M
Isidori, A
Leoni, F
Liso, V
Malagola, M
Martinelli, G
Mecucci, C
Piccaluga, PP
Petti, MC
Rondelli, R
Russo, D
Sessarego, M
Specchia, G
Testoni, N
Torelli, G
Mandelli, F
Tura, S
Citation: G. Visani et al., The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia - analysis of 848 patients, LEUKEMIA, 15(6), 2001, pp. 903-909
Authors:
Clavio, M
Quintino, S
Masoudi, B
Carrara, S
Cerri, R
Pierri, I
Canepa, L
Miglino, M
Muner, P
Damasio, E
Gobbi, M
Citation: M. Clavio et al., Cost of de novo acute myeloid leukemia induction therapy in adults: Analysis of EORTC-GIMEMA AML10 and FLANG regimens, J EXP CL C, 20(2), 2001, pp. 165-173
Authors:
Miglino, M
Grasso, R
Pietrasanta, D
Palmisano, GL
Berisso, G
Clavio, M
Pierri, I
Santini, G
Canepa, L
Gobbi, M
Citation: M. Miglino et al., Detection of minimal residual disease in B-lymphoproliferative disorders: A three step SSCP-PCR method, J EXP CL C, 20(1), 2001, pp. 95-101
Authors:
Miglino, M
Santini, G
Grasso, R
Pietrasanta, D
Clavio, M
Pierri, I
Canepa, L
Nati, S
Ballerini, F
Varaldo, R
Palmisano, G
Gobbi, M
Citation: M. Miglino et al., Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation, HAEMATOLOG, 86(7), 2001, pp. 706-714
Authors:
Santini, G
Nati, S
Spriano, M
Gallamini, A
Pierluigi, D
Congiu, AM
Truini, M
Rubagotti, A
Chisesi, T
Vimercati, R
Rossi, E
Sertoli, MR
Mattei, D
Marino, G
Gobbi, M
Citation: G. Santini et al., Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma, HAEMATOLOG, 86(3), 2001, pp. 282-286
Authors:
Zinzani, PL
Martelli, M
De Renzo, A
Zaccaria, A
Pavone, E
Bocchia, M
Falini, B
Gobbi, M
Gherlinzoni, F
Bendandi, M
Stefoni, V
Tani, M
Tura, S
Citation: Pl. Zinzani et al., Primary mediastinal large B-cell lymphoma with sclerosis: a clinical studyof 89 patients treated with MACOP-B chemotherapy and radiation therapy, HAEMATOLOG, 86(2), 2001, pp. 187-191
Authors:
Balleari, E
Villa, G
Garre, S
Ghirlanda, P
Agnese, G
Carletto, M
Clavio, M
Ferrando, F
Gobbi, M
Mariani, G
Ghio, R
Citation: E. Balleari et al., Technetium-99m-sestaMIBI scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease, HAEMATOLOG, 86(1), 2001, pp. 78-84
Authors:
Gobbi, M
Moia, M
Pirona, L
Morazzoni, P
Mennini, T
Citation: M. Gobbi et al., In vitro binding studies with two Hypericum perforatum extracts - Hyperforin, hypericin and biapigenin - On 5-HT6, 5-HT7, GABA(A)/benzodiazepine, sigma, NPY-Y-1/Y-2 receptors and dopamine transporters, PHARMACOPS, 34, 2001, pp. S45-S48
Authors:
Sacchetti, G
Bernini, M
Gobbi, M
Parini, S
Pirona, L
Mennini, T
Samanin, R
Citation: G. Sacchetti et al., Chronic treatment with desipramine facilitates its effect on extracellularnoradrenaline in the rat hippocampus: studies on the role of presynaptic alpha(2)-adrenoceptors, N-S ARCH PH, 363(1), 2001, pp. 66-72
Citation: M. Gobbi et G. Mastinu, Analytical description and optimization of the dynamic behaviour of passively suspended road vehicles, J SOUND VIB, 245(3), 2001, pp. 457-481
Authors:
Ballestrero, A
Clavio, M
Ferrando, F
Gonella, R
Garuti, A
Sessarego, M
Ghio, R
Gobbi, M
Patrone, F
Citation: A. Ballestrero et al., High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma, INT J ONCOL, 17(5), 2000, pp. 1007-1013
Authors:
Damasio, EE
Clavio, M
Masoudi, B
Isaza, A
Spriano, M
Rossi, E
Casciaro, S
Cerri, R
Risso, M
Nati, S
Siccardi, M
Truini, M
Gobbi, M
Citation: Ee. Damasio et al., Alpha-interferon as induction and maintenance therapy in hairy cell leukemia: a long-term follow-up analysis, EUR J HAEMA, 64(1), 2000, pp. 47-52
Authors:
Zinzani, PL
Magagnoli, M
Moretti, L
De Renzo, A
Battista, R
Zaccaria, A
Guardigni, L
Mazza, P
Marra, R
Ronconi, F
Lauta, VM
Bendandi, M
Gherlinzoni, F
Gentilini, P
Ciccone, F
Cellini, C
Stefoni, V
Ricciuti, F
Gobbi, M
Tura, S
Citation: Pl. Zinzani et al., Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma, J CL ONCOL, 18(4), 2000, pp. 773-779
Authors:
Trovero, F
Gobbi, M
Weil-Fuggaza, J
Besson, MJ
Brochet, D
Pirot, S
Citation: F. Trovero et al., Evidence for a modulatory effect of sulbutiamine on glutamatergic and dopaminergic cortical transmissions in the rat brain, NEUROSCI L, 292(1), 2000, pp. 49-53
Authors:
Vezzani, A
Moneta, D
Mule, F
Ravizza, T
Gobbi, M
French-Mullen, J
Citation: A. Vezzani et al., Plastic changes in neuropeptide Y receptor subtypes in experimental modelsof limbic seizures, EPILEPSIA, 41, 2000, pp. S115-S121
Authors:
Ballestrero, A
Ferrando, F
Garuti, A
Basta, P
Gonella, R
Stura, P
Mela, GS
Sessarego, M
Gobbi, M
Patrone, F
Citation: A. Ballestrero et al., Comparative effects of three cytokine regimens after high-dose cyclophosphamide: Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF, J CL ONCOL, 17(4), 1999, pp. 1296-1303
Authors:
Pierri, I
Clavio, M
Beltrami, G
Cavaliere, M
Lanza, L
Miglino, M
Canepa, L
Pietrasanta, D
Ballerini, F
Quintino, S
Gatto, S
Celesti, L
Carrara, P
Varese, P
Gobbi, M
Citation: I. Pierri et al., GM-CSF, ARA-C, VP-16 and idarubicin (GM-IVA), a short, and effective induction treatment for de novo AML, suitable for the elderly, J EXP CL C, 18(1), 1999, pp. 55-60